The chemical industry has a name for the compounds it spent decades manufacturing, selling, and defending in court: per- and polyfluoroalkyl substances, or PFAS. Scientists and physicians have a different name for them: forever chemicals. They do not break down in the environment. They do not break down in the human body. They accumulate in blood, liver, and breast tissue. They cause kidney cancer, testicular cancer, thyroid disease, and developmental harm in children. There is no safe level of exposure that researchers have identified. The only question has ever been whether the government would require water systems to remove them — or allow industry to delay that requirement indefinitely.
On Monday, the EPA answered that question, at least for now. The Hill reported that the agency proposed to rescind protections for four of the six PFAS types covered under a Biden-era drinking water rule, while allowing water systems additional time to comply with limits on the remaining two. The proposal does not claim the chemicals are safe. It does not dispute the science linking PFAS to cancer and developmental harm. It simply removes the regulatory requirement to do anything about them — for the foreseeable future.
This is not a close call dressed up as a technical dispute. It is the outcome of a sustained, well-funded lobbying campaign by the chemical and manufacturing industries to prevent PFAS regulation from taking effect — and it will be borne, in the body and in the water supply, by the estimated 100 million Americans whose drinking water contains detectable PFAS contamination.
The Biden administration's PFAS rule, finalized in April 2024, set legally enforceable maximum contaminant levels for six PFAS compounds in public drinking water. For PFOA and PFOS — the two most studied and most prevalent — the limits were set at 4 parts per trillion, close to the detection threshold. For four other PFAS compounds, including HFPO-DA (known commercially as GenX), the rule set a hazard index approach that treated the chemicals as a mixture. Water systems were given five years to comply.
That rule represented the first time the federal government had set binding limits on any PFAS compound in drinking water. It was also, immediately, a target. The American Chemistry Council and a coalition of water utilities challenged it in federal court within weeks of its publication, arguing the limits were too stringent and the compliance timeline too short. The legal challenge is still pending. Monday's EPA proposal effectively gives the industry what the courts have not yet delivered.
The mechanism matters here. The EPA is not claiming new science. It is not presenting evidence that PFAS exposure at levels above the Biden-era limits is safe. The agency's own PFAS health advisories, still posted on its website, describe PFOA and PFOS as having "no safe level" of exposure. What the proposal does instead is invoke cost and compliance burden — the standard industry argument whenever environmental regulation threatens profit margins.
PFAS (per- and polyfluoroalkyl substances) are a class of more than 12,000 synthetic chemicals used in nonstick cookware, food packaging, firefighting foam, and industrial processes since the 1940s. The carbon-fluorine bond that makes them useful also makes them nearly indestructible — they persist in soil, water, and human tissue for decades. Health effects linked to PFAS exposure include kidney and testicular cancer, thyroid disease, immune suppression, high cholesterol, and developmental harm in fetuses and children.
Follow the money and the argument collapses. The chemical industry — led by manufacturers including 3M and DuPont's successor companies — spent decades suppressing internal research showing PFAS caused harm, a textbook case of regulatory capture that unfolded over 40 years before the EPA began acting. 3M, which manufactured PFOS until 2002 and knew of its health effects as early as the 1970s, agreed to a $10.3 billion settlement with U.S. public water systems in 2023 — an acknowledgment, in the language of liability, of what the science had long established. DuPont and its spinoffs agreed to a separate $1.185 billion settlement with water utilities the same year.
Those settlements did not clean the water. They compensated utilities for the cost of filtration systems they would need to install to meet the very regulations now being rolled back. The industry, in other words, paid to acknowledge the harm — and is now lobbying to prevent the remedy.
The political architecture of Monday's proposal is worth examining directly. The EPA's current leadership was confirmed in a Senate vote in which several members had received significant contributions from the chemical industry's political action committees. The acting administrator's previous professional history includes work adjacent to industries regulated by the agency. This is not unusual in the history of EPA leadership, and it is not coincidental. The agency that is now proposing to withdraw PFAS protections is led by officials whose career paths and donor networks connect them to the industries that benefit from the withdrawal.
Communities bearing the greatest PFAS burden are not, by and large, the communities with the political influence to contest this. Military families living near bases where AFFF firefighting foam was used for decades — including installations in North Carolina, Michigan, and Colorado — have some of the highest documented PFAS exposure in the country. Rural communities dependent on private wells, which are not covered by EPA drinking water standards at all, have no federal protection regardless of what the rule says. Low-income communities served by smaller water systems, which face the greatest compliance cost burden the industry cites, are simultaneously the communities least able to absorb the health consequences of delay. This is environmental racism operating through the mechanism of regulatory inaction — the communities that can least afford to wait are the ones being told to wait longest.
The international context makes the domestic retreat starker. The European Union's updated Drinking Water Directive, which took effect in January 2021, set a total PFAS limit of 100 parts per trillion across all PFAS compounds — and individual limits of 10 parts per trillion for the most hazardous ones. Denmark, Germany, and the Netherlands have implemented even stricter standards. The European Chemicals Agency has been moving toward a broad-based restriction on PFAS manufacturing and use. The United States, under the Biden rule, had finally moved toward alignment with European standards. Monday's proposal moves it back in the opposite direction, at the precise moment when the science has become more certain, not less.
There is a specific and underreported dimension to the rollback of the four non-PFOA/PFOS compounds. GenX chemicals — the HFPO-DA compound covered under the hazard index approach being rescinded — were developed explicitly as PFOA replacements after regulators began scrutinizing PFOA. The industry marketed them as safer alternatives. Subsequent research found they cause similar kidney and liver damage in animal studies, and the EPA's own health advisories treat them as having negligible safe exposure levels. Rescinding the GenX protections is not protecting Americans from an overreaching rule — it is protecting the manufacturers of a compound that was designed to evade earlier regulation.
The proposal is open for public comment, and water utilities, environmental groups, and public health organizations are expected to file in opposition. Whether that opposition changes the outcome depends on whether the EPA treats the comment process as a genuine regulatory input or as a procedural formality before a predetermined conclusion. Given the alignment between the agency's current leadership, its donor networks, and the proposal itself, the burden of proof runs in one direction.
The children who will bear the developmental consequences of elevated PFAS exposure during the years this rollback is in effect will not be old enough to vote against it for another decade. The cancers that PFAS exposure causes have latency periods measured in years or decades. The political cost of this decision is deferred. The health cost is not. That asymmetry — between who decides and who pays — is the actual policy being implemented here, and it has been the chemical industry's operating model since the 1970s. The only thing that has changed is that the EPA, for a brief period, stopped going along with it. Monday's proposal is an attempt to restore the previous arrangement.
